"Niagara Health is a regional healthcare provider with multiple sites and a growing network of community-based and virtual services. We believe that every person in our region deserves to live every day of their life in the best health possible. As a community-based academic centre, our focus on teaching and learning, research, innovation and partnership propels us to continually improve care and make a difference in people's lives. We provide a full range of acute care hospital services to the 450,000 residents across the Niagara region, and we are one of the few hospitals in Ontario that own and operate a long-term care facility."

During the past decade, Niagara Health System conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 18 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Niagara Health System" #1 sponsor was "NCIC Clinical Trials Group" with 14 trials, followed by "Canadian Cancer Trials Group" with 8 trials sponsored, "Ontario Clinical Oncology Group (OCOG)" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "McMaster University" with 4 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Niagara Health System" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator and "Canadian Cancer Trials Group" with 4 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Niagara Health System" are "Breast Cancer" (19 trials), "Colorectal Cancer" (6 trials), "Lung Cancer" (4 trials), "Depression" (2 trials) and "Fatigue" (2 trials). Many other conditions were trialed in "Niagara Health System" in a lesser frequency.

Most popular intervention types in "Niagara Health System" are "Drug" (36 trials), "Other" (20 trials), "Biological" (9 trials), "Procedure" (9 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "placebo" (6 trials), "paclitaxel" (4 trials), "Gemcitabine" (3 trials) and "adjuvant therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Niagara Health System" are 37 trials for "All" genders, 18 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Niagara Health System". 1 are not yet recruiting, 10 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Niagara Health System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Niagara Health System, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".